Swainsonine
Overview
Swainsonine is a potent inhibitor of Golgi alpha-mannosidase II, immunomodulator and potential anticancer agent. Disruption of Golgi alpha-mannosidase II with swainsonine induces hybrid-type glycans. These glycans have a Man5GlcNAc2 core with processing on the 3-arm that resembles so-called complex-type glycans.
The pharmacological properties of this product have not been fully investigated.
Handling Instructions
- Soluble in water (10 mg/1 ml) and ethanol
- Use caution when handling.
- This product must not be used in humans
- Store between 0-4 ˚C for up to 1 year
- Store or 20 ˚C for up to 3 months
- Disposal: A
References
- Swainsonine at Logan Natural Products
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
